Control of the chemical step by leucine-31 of pancreatic phospholipase A2.
A well-defined region of pancreatic and other secreted phospholipase A2 (PLA2), which we call the i-face, makes a molecular contact with the interface to facilitate and control the events and processivity of the interfacial catalytic turnover cycles. The structural features of the i-face and its allosteric relationship to the active site remain to be identified. As a part of the calcium binding (26-34) loop, Leu-31 is located on the surface near the substrate binding slot of PLA2. Analysis of the primary rate and equilibrium parameters of the Leu-31 substitution mutants of the pig pancreatic PLA2 shows that the only significant effect of the substitution is to impair the chemical step at the zwitterionic interface in the presence of added NaCl, and only a modest effect is seen on kcat at the anionic interface. Leu-31 substitutions have little effect on the binding of the enzyme to the interface; the affinity for certain substrate mimics is modestly influenced in W3F, L31W double mutant. The fluorescence emission results with the double mutant show that the microenvironment of Trp-31 is qualitatively different at the zwitterionic versus anionic interfaces. At both of the interfaces Trp-31 is not shielded from the bulk aqueous environment as it remains readily accessible to acrylamide and water. The NaCl-induced change in the Trp-31 emission spectrum of the double mutant on the zwitterionic interface is similar to that seen on the binding to the anionic interface. Together, the kinetic and spectroscopic results show that the form of PLA2 at the zwitterionic interface (Ez) is distinguishably different from the catalytically more efficient form at the anionic interface (Ea). This finding provides a structural basis for the two-state model for kcat activation by the anionic interface. In conjunction with earlier results we suggest that neutralization of certain cationic residues of PLA2 exerts a control on the calcium loop through residue 31.
Yu
B Z
BZ
Department of Chemistry and Biochemistry, University of Delaware, Newark, Delaware 19716, USA.
Janssen
M J
MJ
Verheij
H M
HM
Jain
M K
MK
D019943:Amino Acid Substitution / Q000235:genetics; D000818:Animals; D000838:Anions; D001667:Binding, Competitive; D002384:Catalysis; D004791:Enzyme Inhibitors / Q000737:chemistry; D020404:Glycerophospholipids / Q000737:chemistry; D006868:Hydrolysis; D007700:Kinetics; D007930:Leucine / Q000737:chemistry* / Q000235:genetics; D008244:Lysophosphatidylcholines / Q000737:chemistry; D008823:Micelles; D010741:Phospholipases A / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000235:genetics; D054467:Phospholipases A2; D017354:Point Mutation; D013050:Spectrometry, Fluorescence; D013552:Swine; D014364:Tryptophan / Q000737:chemistry / Q000235:genetics
D000838:Anions; D004791:Enzyme Inhibitors; D020404:Glycerophospholipids; D008244:Lysophosphatidylcholines; D008823:Micelles; C029313:dimyristoylmethylphosphatidic acid; D014364:Tryptophan; D010741:Phospholipases A; D054467:Phospholipases A2; D007930:Leucine